Has Eltrombopag eliminated the need to use allogeneic HSCT in first line treatment of pediatric aplastic anemia?

Pediatr Hematol Oncol

Division of Pediatric Hematology, Oncology and BMT, Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.

Published: August 2021

Download full-text PDF

Source
http://dx.doi.org/10.1080/08880018.2021.1940579DOI Listing

Publication Analysis

Top Keywords

eltrombopag eliminated
4
eliminated allogeneic
4
allogeneic hsct
4
hsct treatment
4
treatment pediatric
4
pediatric aplastic
4
aplastic anemia?
4
eltrombopag
1
allogeneic
1
hsct
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!